ANI PharmaceuticalsvsEli Lilly and Company

ANIP and LLY stock compared: price, dividend, valuation and results, from SEC filings.

ANIP

ANI Pharmaceuticals, Inc.

$71.47

Value $1.6B

+2.11%
ANIP's page

LLY

Eli Lilly and Company

$1,382.75

Value $1.30T

-2.32%
LLY's page

ANI Pharmaceuticals (ANIP) has a market value of $1.6B and Eli Lilly and Company (LLY) $1.30T. Over the last year, with dividends, ANIP moved -12.8% and LLY +36.2%. The P/E is 13.9 for ANIP and 47.3 for LLY. Dividend yield: ANIP none, LLY 0.46%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ANIP$1.6B

    LLY$1.30T

    LLY is 811 times ANIP

  • Revenue, 12 months

    ANIP$1.0B

    LLY$86.5B

    LLY is 83 times ANIP

  • Net income, 12 months

    ANIP$117M

    LLY$27.6B

    LLY is 236 times ANIP

  • Operating margin

    ANIP16.0%

    LLY–

  • ROIC

    ANIP14.1%

    LLY35.5%

    21.4 points apart

  • P/E

    ANIP13.9

    LLY47.3

    LLY is 3.4 times ANIP

  • Dividend yield

    ANIP0.0%

    LLY0.5%

    0.5 points apart

  • 5-year return

    ANIP+63.5%

    LLY+452.8%

    389.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ANIP+63.5%

LLY+452.8%

20040060020222023202420252026
Returns by period
PeriodANIPWith dividendsLLYWith dividends
1 year since November 17, 2025-12.8%Price -12.8%+36.2%Price +35.3%
3 years since November 17, 2023+39.1%+11.6% a yearPrice +39.1%+138.4%+33.6% a yearPrice +133.7%
5 years since November 17, 2021+63.5%+10.3% a yearPrice +63.5%+452.8%+40.8% a yearPrice +429.4%
10 years since November 18, 2016+23.2%+2.1% a yearPrice +23.2%+1,997.9%+35.6% a yearPrice +1,703.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ANIPANI PharmaceuticalsLLYEli Lilly and Company

Valuation

ANIPLLY
Valuation
Price$71.47$1,382.75
Market value$1.6B$1.30T
Enterprise value (EV)$1.5B$1.35T
P/E13.947.3
P/E, 5-year median–49.9
P/B2.532.4
EV/EBIT8.938.8
Free cash flow yield12.8%1.5%

Results and growth

ANIPLLY
Results and growth
Revenue, 12 months$1.0B$86.5B
Net income, 12 months$117M$27.6B
Free cash flow, 12 months$205M$19.7B
Earnings per share, 12 months$5.01$30.81
Revenue growth, year on year43.8%44.7%
Revenue growth a year, past+33.5%over 5 years+21.6%over 5 years
EPS growth a year, past–+27.6%over 5 years

Margins and returns on capital

ANIPLLY
Margins and returns on capital
Gross margin61.1%83.6%
Operating margin16.0%–
Net margin11.2%31.9%
ROIC14.1%35.5%
ROE20.5%88.6%

Balance sheet

ANIPLLY
Balance sheet
Cash$421M$4.9B
Total debt$298M$49.5B
Net debt / EBITDA-0.51.2
Interest cover5.4×38.9×

Dividends and buybacks

ANIPLLY
Dividends and buybacks
Dividend yield–0.5%
Dividend per share, 12 months–$6.34
Dividend growth a year, past+36.1%over 4 years+15.2%over 5 years
Buyback yield0.8%0.3%
Shareholder yield0.8%0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ANIP or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, ANI Pharmaceuticals or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.30T) is about 811.5 times ANI Pharmaceuticals ($1.6B), at today's prices.

How did ANIP and LLY stock do over the last 10 years?

Since November 18, 2016, ANIP's price moved +23.2% and LLY's +1,703.5%. With dividends: ANIP +23.2% (+2.1% a year), LLY +1,997.9% (+35.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, ANIP or LLY?

The dividend yield at today's price is none for ANI Pharmaceuticals and 0.46% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

What is the P/E of ANIP and LLY?

At today's price, the P/E is 13.9 for ANIP and 47.3 for LLY. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, ANI Pharmaceuticals or Eli Lilly and Company?

Over the last twelve months, the net margin was 11.2% for ANI Pharmaceuticals and 31.9% for Eli Lilly and Company, and the operating margin 16.0% and –. Revenue was $1.0B and $86.5B.

Which is the better investment, ANI Pharmaceuticals or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.